American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2

Despite a paucity of direct evidence, 74 draft guidance statements were developed to provide guidance for use of the COVID-19 vaccines in this population and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination.

Source:

Arthritis & Rheumatology